FDA approves selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors
FDA approves selpercatinib for locally advanced or metastatic RET fusion-positive solid tumors
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Drugs & Pharmacology